Correlation Between John B and Canopus BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both John B and Canopus BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining John B and Canopus BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between John B Sanfilippo and Canopus BioPharma Incorporated, you can compare the effects of market volatilities on John B and Canopus BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in John B with a short position of Canopus BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of John B and Canopus BioPharma.

Diversification Opportunities for John B and Canopus BioPharma

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between John and Canopus is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding John B Sanfilippo and Canopus BioPharma Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canopus BioPharma and John B is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on John B Sanfilippo are associated (or correlated) with Canopus BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canopus BioPharma has no effect on the direction of John B i.e., John B and Canopus BioPharma go up and down completely randomly.

Pair Corralation between John B and Canopus BioPharma

Given the investment horizon of 90 days John B is expected to generate 11.85 times less return on investment than Canopus BioPharma. But when comparing it to its historical volatility, John B Sanfilippo is 17.77 times less risky than Canopus BioPharma. It trades about 0.15 of its potential returns per unit of risk. Canopus BioPharma Incorporated is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Canopus BioPharma Incorporated on October 30, 2024 and sell it today you would earn a total of  0.00  from holding Canopus BioPharma Incorporated or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy94.74%
ValuesDaily Returns

John B Sanfilippo  vs.  Canopus BioPharma Incorporated

 Performance 
       Timeline  
John B Sanfilippo 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days John B Sanfilippo has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, John B is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Canopus BioPharma 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Canopus BioPharma Incorporated are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain forward indicators, Canopus BioPharma sustained solid returns over the last few months and may actually be approaching a breakup point.

John B and Canopus BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with John B and Canopus BioPharma

The main advantage of trading using opposite John B and Canopus BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if John B position performs unexpectedly, Canopus BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canopus BioPharma will offset losses from the drop in Canopus BioPharma's long position.
The idea behind John B Sanfilippo and Canopus BioPharma Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies